Serious side effects are rare but include pancreatitis risk in susceptible individuals
The superoxide anion radical is usually involved in both damaging and regulatory processes
As the gut microbiome begins to rebalance, continued use supports ongoing digestive comfort and gut health over time
NextMed Founded: 2020 Total raised: Undisclosed What NextMed does: NextMed began as a COVID-19 testing startup but moved into prescribing GLP-1s for weight loss in July 2022
Whilst the evidence base remains limited, emerging data show greater cardiac mass amongst AAS users (Far et al, 2012) and evidence of significantly reduced ejection fraction and higher coronary artery plaque volume among current AAS users, as compared to non-users or those currently off cycle (Baggish et al, 2017)
As of December 2025, GLP-1 RA prescriptions account for more than 7% of all prescriptions